Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers

Urological Research

Volumn 35, Issue 5, 2007, Pages 247-251

  Negri, Armando Luis ^a   Spivacow, Rodolfo ^a   Del Valle, Elisa ^a   Pinduli, Irene ^a   Marino, Alicia ^a   Fradinger, Erich ^a   Zanchetta, Jose Ruben ^a  

^a UNIVERSIDAD DEL SALVADOR   (Argentina)

Author keywords

Calcium oxalate stones; Overweight; Stone former; Uric acid stones; Urinary acidification; Urinary pH

Indexed keywords

CALCIUM OXALATE; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; FEMALE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OBESITY; PRIORITY JOURNAL; STONE ANALYSIS; STONE FORMATION; URIC ACID STONE; URIC ACID URINE LEVEL; URINE ACIDIFICATION; URINE PH; COMPARATIVE STUDY; KIDNEY DISEASE; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; ONSET AGE; URINE;

ADULT; AGE OF ONSET; CALCIUM OXALATE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NEPHROLITHIASIS; URIC ACID;

EID: 38349031083     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-007-0109-1     Document Type: Article

References (27)

1. Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisan E (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 37(1):23-25
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63(5):1817-1823
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295(13):1549-1555
4. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the National Health and Nutrition Examination Survey. JAMA 287(3):356-359
5. Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9(9):1645-1652
6. Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293(4):455-462
7. Nishio S, Yokoyama M, Iwata H, Takenuchi M, Kamei O, Sugamoto T, Saike Y, Ochi K, Kin M, Aoki K, Nabeshima S, Takeda H, Takei S (1998) Obesity is one of the risk factors for urolithiasis. Nippon Hinyokika Gakkai Zasshi 89:573
8. Curhan GC, Willet WC, Speizer FE, Stampfer MJ (2001) Twenty-four hour-urine chemistries and the risk of kidney stones among women and men. Kidney Int 59(6):2290-2298
9. Daudon M, Lacour B, Jungers P (2006) Influence of body size on urinary stone composition in men and women. Urol Res 34(3):193-199
10. Mandel NS, Mandel GS (1989) Urinary tract stone disease in the United States veteran population II. Geographical analysis of variations in composition. J Urol 142:1516-1521
11. Scholz D, Schwille PO, Ulbrich D, Bausch WM, Seigel A (1979) Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine. Urol Res 7:161-170
12. Tiselius HG (2003) Epidemiology and medical management of stone disease. BJU Int 91:758-767
13. Henneman PH, Wallach S, Dempsey E (1962) The metabolic defect responsible for uric acid stone formation. J Clin Invest 41:537-542
14. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH (2001) Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60:757-761
15. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65(4):1422-1425
16. Siener R, Glatz S, Nicolay C, Hesse A (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106-113
17. Lemann J, Pleuss J, Worcester E, Hornick L, Schrab D, Hoffmann R (1996) Urinary oxalate excretion increases with body seize and decreases with increasing calcium intake among healthy adults. Kidney Int 49:200-208
18. World Health Organization (2000) Obesity: preventing and managing the global epidemic. WHO obesity technical report series 894. World Health Organization, Geneva
19. Welshman SG, McCambridge H (1973) The estimation of citrate in serum and urine using a citrate lyase technique. Clin Chim Acta 46:243-246
20. Tiselius HG (1996) Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pack CY, parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-raven, Philadelphia, pp 33-64
21. Breslau NA, Brinkley L, Hill KD, Pak CYC (1988) Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 66:140-146
22. Wyngaarden JB, Kelly WN (1972) Gout. In: Stanbury JB, Wyngaarden JB, Fredrikson DS (eds) The metabolic basis of inherited diseases. McGraw-Hill, New York, pp 889-967
23. Rieselback RE, Sorenson LB, Shelp WD, Steele TH (1970) Diminished urate secretion per nephron as a basis for primary gout. Ann Intern Med 73:359-366
24. Yki-Jarvinen H, Taskinen MR (1988) Interrelationship among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetics and diabetic patients with endogenous hypertriglyceridemia. Diabetes 37:1271-1278
25. Yano K, Rhoads GC, Kagan A (1977) Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis 30:171-184
26. Zechner O, Pfluger H, Scheiber V (1982) Idiopathic uric acid lithiasis: epidemiologic and metabolic aspects. J Urol 128(6):1219-1223
27. Bollack C, Reinhardt W, Goldschmidt P, D'Ancona C (1981) Personal experience of urate lithiasis. J Urol 87(4):231-233